MedPath

河北仁合益康药业有限公司

Ownership
-
Established
2011-11-28
Employees
-
Market Cap
-
Website
www.121.28.192.230

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

16

NMPA:16

Drug Approvals

Balanced Salt Solution Irrigating

Product Name
平衡盐溶液(供灌注用)
Approval Number
国药准字H20234556
Approval Date
Nov 28, 2023
NMPA

Balanced Salt Solution Irrigating

Product Name
平衡盐溶液(供灌注用)
Approval Number
国药准字H20234555
Approval Date
Nov 28, 2023
NMPA

Multiple Electrolytes Injection

Product Name
复方电解质注射液
Approval Number
国药准字H20234469
Approval Date
Nov 14, 2023
NMPA

Guaifenesin and Bromhexine Hydrochloride Oral Solution

Product Name
愈酚溴新口服溶液
Approval Number
国药准字H20183429
Approval Date
Sep 7, 2023
NMPA

Oxiracetam Injection

Product Name
奥拉西坦注射液
Approval Number
国药准字H20183103
Approval Date
Apr 27, 2023
NMPA

Iron Proteinsuccinylate Oral Solution

Product Name
蛋白琥珀酸铁口服溶液
Approval Number
国药准字H20233388
Approval Date
Mar 24, 2023
NMPA

Risperidone Oral Solution

Product Name
利培酮口服液
Approval Number
国药准字H20183011
Approval Date
Jan 29, 2023
NMPA

Sodium Acetate Ringer's Injection

Product Name
醋酸钠林格注射液
Approval Number
国药准字H20223877
Approval Date
Nov 22, 2022
NMPA

Dexmedetomidine Hydrochloride Injection

Product Name
盐酸右美托咪定注射液
Approval Number
国药准字H20223495
Approval Date
Jul 7, 2022
NMPA

Terbutaline Sulfate Nebuliser Solution

Product Name
硫酸特布他林雾化吸入用溶液
Approval Number
国药准字H20217058
Approval Date
Jul 7, 2021
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.